$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
Analysis of vorasidenib-VORANIGO reimbursement conditions and explanations of medical insurance policies and patient fees in different regions
2026-02-01 22:25:32
Check Details
How effective is Zongatinib (Zongatinib), its clinical trial results, patient experience and real feedback
2026-02-01 22:25:32
Check Details
Detailed description of the usage and dosage of vosoritide and the clinical medication regimen for patients of different ages and weights
2026-02-01 22:25:32
Check Details
Which diseases require the use of Methylcobalamin Injection (Rozebalamin) and classification of typical indications
2026-02-01 22:25:32
Check Details
Important indications for Trientine
2026-02-01 22:25:32
Check Details
Detailed interpretation of the instructions for use of mirikizumab
2026-02-01 22:25:32
Check Details
What are the possible consequences of long-term use of selumetinib/coceyu?
2026-02-01 22:25:32
Check Details
Lorlatinib/lorlatinib (Borina) belongs to the first generation of anti-cancer drugs
2026-02-01 22:25:32
Check Details
What drug class does Cabozantinib belong to?
2026-02-01 22:25:32
Check Details
What is the drug name of Bosutinib/Bosutinib?
2026-02-01 22:25:32
Check Details
What is the price of Upadacitinib and how do patients choose it?
2026-02-01 22:25:32
Check Details
Manufacturer and brand information of Teclistamab
2026-02-01 22:25:32
Check Details
1
2
...
87
88
89
90
91
92
93
...
104
105
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
How much does a box of lenvatinib/lenvatinib capsules cost, and can it be reimbursed?
2
Which manufacturer produces Belumosudil tablets and what is the quality?
3
Tips on possible risks of using Brivaracetam
4
The application effect of Alpelisib in advanced breast cancer
5
What are the adverse reactions of fostatinib/fotantinib?
6
Is serputinib/serpatinib (Ruitu) a targeted anti-cancer drug?
7
Bezutivan combined with pembrolizumab and lenvatinib shows potential in advanced clear cell renal cell carcinoma
8
How to follow and implement the usage and dosage of Besudil/Elac
9
2026 Brivaracetam market price and price trend reference
10
How does the efficacy of Alpelisib compare with everolimus?
11
How to buy genuine fotantinib/fotantinib medicines
12
Analysis of possible resistance to serputinib/serpatinib (Ruitu)